EFFECTIVENESS AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARINS (LMWH) IN THE PREVENTION OF VENOUS THROMBOEMBOLISM (VTE)

被引：0
作者：
KAKKAR, VV
机构：
来源：
THROMBOSIS AND HAEMOSTASIS | 1995年 / 74卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：364 / 368
页数：5
相关论文
共 23 条
[1]  
BEGUIN S, 1992, THROMB HAEMOSTASIS, V67, P33
[2]  
BENDETOWICZ AV, 1992, THROMB HAEMOSTASIS, V67, P556
[3]   ORG 10172 - A LOW-MOLECULAR-WEIGHT HEPARINOID ANTICOAGULANT WITH A LONG HALF-LIFE IN MAN [J].
BRADBROOK, ID ;
MAGNANI, HN ;
MOELKER, HCT ;
MORRISON, PJ ;
ROBINSON, J ;
ROGERS, HJ ;
SPECTOR, RG ;
VANDINTHER, T ;
WIJNAND, H .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (06) :667-675
[4]  
BRANDT A, 1995, UNPUB COST EFFECTIVE
[5]  
CARTER CJ, 1982, BLOOD, V59, P1237
[6]  
DRUMMOND M, 1994, BRIT J SURG, V81, P1974
[7]   COMPARISON BETWEEN COMMERCIAL HEPARIN, LOW-MOLECULAR WEIGHT HEPARIN AND PENTOSAN POLYSULFATE ON HEMOSTASIS AND PLATELETS INVIVO [J].
ESQUIVEL, CO ;
BERGQVIST, D ;
BJORCK, CG ;
NILSSON, B .
THROMBOSIS RESEARCH, 1982, 28 (03) :389-399
[8]   CHEMICAL AND BIOLOGICAL HETEROGENEITY IN LOW-MOLECULAR WEIGHT HEPARINS - IMPLICATIONS FOR CLINICAL USE AND STANDARDIZATION [J].
FAREED, J ;
WALENGA, JM ;
HOPPENSTEADT, D ;
RACANELLI, A ;
COYNE, E .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1989, 15 (04) :440-463
[9]  
FRYDMAN A, 1988, J CLIN PHARMACOL, V28, P608
[10]  
HIRSH J, 1979, BLOOD, P1
123